35: Lumbar Total Disk Arthroplasty

Published on 21/04/2015 by admin

Filed under Surgery

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1272 times

Procedure 35 Lumbar Total Disk Arthroplasty

Indications

Portals/Exposures

Procedure

Evidence

Bertagnoli R, Yue JJ, Shah RV, et al. The treatment of disabling single-level lumbar diskogenic low back pain with total disc arthroplasty utilizing the ProDisc prosthesis: a prospective study with 2-year minimum follow-up. Spine. 2005;30:2230-2236.

This is a prospective study with 2-year follow-up presenting the results of total disk replacement (TDR) in 118 patients with diskogenic low back pain. A single-level TDR was performed at L3-S1, with outcome measurements taken at 3, 6, 12, and 24 months after surgery. The authors found that improvements in the Visual Analogue Scale, the Oswestry Disability Index, and patient satisfaction occurred at 3 months and were maintained at 24 months, all with statistical significance. At the index level, disk height increased from 4 to 13 mm, and segmental motion increased from 3 to 7 degrees, both with statistical significance as well. They concluded that TDR is a successful alternative to fusion, with consistent results at 2-years follow-up. Although this is a prospective case series, it legitimizes TDR as a treatment option for disabling low back pain resulting from diskogenic syndrome.

Blumenthal S, McAfee PC, Guyer RD, et al. A prospective, randomized, multicenter Food and Drug Administration Investigational Device Exemptions study of lumbar total disc replacement with the CHARITE Artificial Disc versus lumbar fusion: part I: evaluation of clinical outcomes. Spine. 2005;30:1565-1575.

This is a Level I study comparing total disk replacement (TDR) with anterior lumbar interbody at a single level from L4-S1. A total of 304 patients were randomized. Both groups showed significant improvement following surgery. Patients in the TDR group were found to have lower levels of disability at every time interval from 6 weeks to 24 months. At the 24-month follow-up period, a greater percentage of patients in the TDR group were satisfied with their treatment compared with the fusion group (P < .05). The complication rates were similar between the groups, and the hospital stay was significantly shorter for TDR than for fusion patients. Reoperation was higher in the fusion group (9.1% versus 5.4%).

Brau SA, Delamarter RB, Schiffman ML, et al. Vascular injury during anterior lumbar surgery. Spine J. 2004;4:409-412.

This publication is a retrospective case series of 1315 consecutive patients who underwent anterior approach to the lumbar spine. A significant vascular complication rate of 1.9% was reported. Six patients had left iliac artery thrombosis, and 19 patients had major venous injuries. The study concluded that anterior lumbar surgery is safe, although special attention should be given during mobilization of the vessels to avoid serious complications.

David T. Long-term results of one-level lumbar arthroplasty: minimum 10-year follow-up of the CHARITE Artificial Disc in 106 patients. Spine. 2007;32:661-666.

This was a Level III study with long-term follow-up of total disk arthroplasty patients. Eighty percent of patients reported excellent or good clinical success after Charité total disk replacement (TDR) at a mean of 13.2-years follow-up. Ninety percent of the prostheses were still mobile. The reoperation rate for TDR patients was 7.5% and the adjacent level degeneration rate was found to be 2.8%. Almost 90% of the patients returned to work after TDR. The complications rate was 4.6%, with a 2.8% rate of subsidence and less than a 2% rate of core subluxation.

Guyer RD, McAfee PC, Banco RJ, et al. Prospective, randomized, multicenter Food and Drug Administration Investigational Device Exemption study of lumbar total disc replacement with the CHARITE Artificial Disc versus lumbar fusion: five-year follow-up. Spine J. 2009;9:374-386.

This represents a Level I study comparing total disk replacement (TDR) and fusion at the 5-year follow-up time point. Five-year follow-up was completed by 133 randomized patients. Overall success was defined as improvement of at least 15 points on the Oswestry Disability Index (ODI) versus baseline, no device failure, absence of major complications, and maintenance or improvement of neurologic status. The overall success was 57.8% in the TDR group versus 51.2% in the fusion group. Changes from baseline for ODI, Visual Analogue Scale pain scores, and SF-36 Health Survey Scores were similar for both groups. In patient satisfaction surveys, 78% of TDR patients were satisfied versus 72% of fusion patients. Higher rates of employment were noted in the TDR group. Long-term disability was higher in the fusion group by nearly threefold (P = .0441). Additional index-level surgery was also higher for the fusion group. Radiographic data were similar to that reported in the 2-year follow-up study (see Blumenthal et al, 2005, this section).

Guyer RD, Tromanhauser SG, Regan JJ. An economic model of one-level lumbar arthroplasty versus fusion. Spine J. 2007;7:558-562.

A cost-minimization model comparing costs of total disk replacement (TDR) to three spinal fusion procedures: anterior lumbar interbody fusion (ALIF) with iliac crest bone graft (ICBG), ALIF with INFUSE Bone Graft and LT-Cages, and instrumented posterior lumbar interbody fusion (IPLIF) with ICBG. The hospital perspective compares direct medical costs during the index hospitalization. The payer perspective considers direct medical costs of the index hospitalization and those incurred in the following 2-year period. Compared with TDR, hospital costs are 12.0% higher for ALIF with ICBG, 36.5% higher for ALIF with INFUSE, and 36.5% higher for IPLIF. For payers, compared with TDR, ALIF with ICBG has 4.4% lower cost, whereas ALIF with INFUSE and IPLIF have costs of 16.1% and 27.1% higher, respectively. The study concluded that the overall economic effect of one-level TDR procedures (for payers and hospitals) is at worst equivalent to fusion.

Lemaire JP, Carrier H, Sariali el-H, et al. Clinical and radiological outcomes with the Charité Artificial Disc: a 10-year minimum follow-up. J Spinal Disord Tech. 2005;18:353-359.

This is a long-term series with a minimum follow-up of 10 years. A total of 107 patients underwent lumbar total disk replacement (TDR): 54 one-level and 45 two-level procedures, and 1 three-level procedure. Clinically, 62% had an excellent outcome, 28% had a good outcome, and 10% had a poor outcome. Greater than 90% of eligible patients returned to work. Motion measurements showed 10.3 degrees of flexion/extension for all levels. No subluxation of the implants was noted, and no cases of arthrodesis occurred. Five patients required a secondary posterior arthrodesis because of poor clinical outcomes, not because of catastrophic device failure.

Zigler J, Delamarter R, Spivak JM, et al. Results of the prospective, randomized, multicenter Food and Drug Administration Investigational Device Exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine. 2007;32:1155-1162.

This is another Level I study comparing total disk replacement (TDR) to circumferential spinal fusion for the treatment of diskogenic pain at a single level between L3 and S1. The study involved 286 patients. No major complications occurred in the investigational group. At 2-years follow-up, 77.2% of investigational and 64.8% of control patients met the Oswestry Disability Index improvement criteria of at least 15%. Overall neurologic success in the investigational group was superior to the control group. Visual Analogue Scale improvement was superior at 24 months in the investigational group versus the control group (P = .015). Radiographic range of motion averaged 7.7 degrees in the TDR patients and was of normal values in more that 90% of these. TDR not only showed non-inferiority to fusion, it showed superiority on several clinical parameters.